Hydrogen sulfide (H 2 S) is now admitted as a third gasotransmitter together with nitric oxide (NO) and carbon monoxide (CO), albeit it was originally considered as a foul and poisonous gas. Endogenous H 2 S production in mammalian cells is counting on the three enzymes acting on cysteine. Involvement of H 2 S in various physiological and pathological processes has been extensively studied in the last fifteen years. Mounting evidence suggests that H 2 S is able to protect against atherosclerosis development and progression. Exogenous H 2 S supplement has salutary effects on atherogenesis, and reduction of the endogenous H 2 S level accelerates atherosclerosis. The anti-atherosclerotic mechanisms of H 2 S have been descried in different aspects, including endothelium preservation, antioxidative action, anti-inflammatory responses, vasorelaxation, regulation of ion channels, etc. However, further investigation is still needed to help us gain more insights into the fundamental underlying mechanisms, and that will allow us to design better therapeutic applications of H 2 S in the treatment of atherosclerosis.
Introduction
H 2 S made its landfall in gasotransmitter field 15 years ago [1] , being recognized as the third gasotransmitter alongside with nitride oxide (NO) and carbon monoxide (CO). Like NO and CO, H 2 S is widely implicated in the physiological and pathophysiological processes in both prokaryotes and eukaryotes. It is known that these anaerobic gases ubiquitously existed and may serve as an energy source in the ancient earth where considering amount of oxygen was available. So it is reasonable that these three gasotransmitters profoundly affect Interactions with ion channels H 2 S, as an endothelium-derived hyperpolarizing factor (EDHF) being recently identified, exerts vasorelaxant effects by influencing many ion channels, partially explained by sulfhydrating vasorelaxation related ion channels [20] . To date, it activates small-and intermediate-conductance calcium-activate potassium channels (SK Ca and IK Ca channels, respectively) and induces endothelium-dependent smooth muscle hyperpolarization, which can be stopped by the co-application of charybdotoxin and apamin [21] . The mechanism of H 2 S playing a role as an EDHF is partly elucidated by H 2 S sulfhydrating IK Ca channels in primary human aortic endothelial cells [20] . Not limiting to SK Ca and IK Ca channels, it has been reported that H 2 S dilates phenylephrine (PE)-constricted rat mesenteric arteries by activating endothelial big-conductance calcium-activated potassium channels (BK Ca ) [22] and CYP2C and then triggers vascular smooth muscle cells (VSMCs) Ca 2+ sparks, which can be inhibited by ryanodine (ryanodine receptor blocker), iberiotoxin (BK Ca blocker), endothelium denudation and sulfaphenazole (CYP2C inhibitor) [23] .
Besides conductance calcium activated potassium channels, H 2 S also activates ATPsensitive potassium channels (K ATP channels) to mediate H 2 S-evoked vasodilation [5] . The stimulation of K ATP channels in VSMC partially demonstrates the vasorelaxant effects of H 2 S [24, 25] . As the molecular target of H 2 S, the sulfonylurea receptor 1 (SUR1) subunit of K ATP channels through mutagenesis in HEK-293 cells [26] and the SUR2B subunit of K ATP channels in colonic smooth muscle cells [27] can be sulfhydrated by H 2 S. K ATP channels, 4-Aminopyridine (4-AP)-sensitive potassium channels are also contributed to NaHS-induced relaxation in rat coronary artery [28] . Besides, H 2 S mediates rat mesenteric arteries vasorelaxation through the release of neurotransmitters by sensory nerves' transient receptor potential ankyrin 1 (TRPA1) channels activation [29] .
H 2 S plays synergistically with NO to form polysulfides (H 2 S n ) to act as TRPA1 channel activator in vasodilation [30] . Meanwhile, ZYZ-803, a slow-releasing H 2 S-NO hybrid molecule, could exert vasorelaxant effect [31] and angiogenesis [32] activity better than S-Propargyl-Cysteine (SPRC) and furoxan alone or together. And as reported recently, H 2 S could upregulate and stabilize the endothelial nitric oxide synthase by facilitating miRNA-455-3p expression [33] . And H 2 S could down regulate inducible NOS (iNOS) expression in LPS-induced acute lung injury [34] .
Interactions with second messengers
Considering the wide scope of influence of H 2 S, inevitably H 2 S affects second messengers although it can also directly affect the target protein alone. Cytosol free calcium is a classical second messenger in cellular signal transduction. Effects of H 2 S on calcium handling in specific cells differ. In endothelial cells, H 2 S can raise intracellular calcium levels by either triggering calcium influx [35] or stimulating an ATP-and 4-CEP sensitive intracellular calcium pool [36] , thus activating many calcium-dependent signaling pathways such as endothelial cells migration [37] and metabolism or adjusted function ensuing. H 2 S triggers calcium sparks in VSMCs in rat mesenteric arteries [23] and pig cerebral arterioles [38] . Calcium sparks stimulate transient K Ca channels and consequent plasma membrane hyperpolarization which concretely manifests vasodilation. Actions on cardiomyocytes of H 2 S are biphasic, not only inhibiting L-type and T-type VDCCs but also increasing calcium release from intracellular calcium pool [39] , of which the realistic functional consequence has not been clarified. In turn, calcium-sensing receptor (CaSR) regulates the endogenous CSE/ H 2 S pathway to achieve the inhibition of proliferation of VSMCs in diabetic models [40] and the protective effects in high glucose-induced cardiotoxicity via inhibition of nucleotide-binding domain, leucine-rich-containing family, pyrin domaincontaining-3 (NLRP3) inflammasome activation [41] and NADPH oxidase 4 (NOX4) inhibition [42] .
Besides, H 2 S inhibits adenylyl cyclase and stimulates phosphodiesterases (PDEs) to make the concentration of cyclic AMP decline [43] . However, it has been reported that H 2 S inhibits PDEs in many studies [44, 45] . How this contradiction occurs will raise the issue of whether the effect of H 2 S is tissue specific.
Post-translational modification : proteins sulfhydration
Protein S-sulfhydration is ubiquitous in vivo. It has been reported that S-sulfhydration can be detected by biotin-switch assay [46] and tag-witch method [47, 48] . For instance, Kelch-lick ECH-associated protein 1 (KEAP1), a negative protein factor of nuclear factor erythroid 2-related factor 2 (NRF2), can be sulfhydrated at the Cys151, but not Cys273, by H 2 S to dissociate with NRF2, hence, the NRF2-related antioxidant responses was enhanced [49, 50] and subsequent diabetes-accelerated atherosclerotic progress was ameliorated [51] .
H 2 S and antioxidant defences
Redox includes oxidation and reduction processes, where electrons migrate from the reductant to oxidant. Redox balance shift reflects the homeostasis change, more specifically, higher oxidant stress and/or lower reductive ability contributes to numerous pathological processes and molecule and cell damage. The antioxidant effects of H 2 S have been clearly established, not only because of its reductive chemical nature, but also its ability of regulating lots of protein and signaling pathways [52] . H 2 S destroys lipid hydroperoxides in oxidized low-density lipoprotein (ox-LDL) [53] . In addition to hydroperoxides, H 2 S scavenges oxidants including superoxide [54] 
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Sirtuin 1 (SIRT1) and H 2 S
Although evidence has been pointed to the direct actions of H 2 S to hamper the development of atherosclerosis, whether other molecular mechanisms are involved in antiatherogenesis effect of H 2 S is well worth considering. SIRT1, functions as a NAD + -dependent histone deacetylase, is highly distributed in the vasculature [57] and is implicated in the field of aging, metabolism [58] . Previous studies have demonstrated that SIRT1 played a major role in regulating the vascular tone [59] [60] [61] and down regulation of atherosclerosis [61, 62] . It has been reported that mice overexpression of SIRT1 preserved the endothelium function comparing with that of WT littermates fed with high-fat diet and overexpression of SITR1 in ApoE -/-mice developed less atherosclerotic lesions compared with the ApoE -/-controls [61] . The mechanism of SIRT1 improving atherosclerosis may include dilating arteries [59] , preserving function of endothelium [60] and preventing endothelial senescence [63] , downregulating neointima formation [64] and vascular modeling [65] , decreasing Lox-1-induced foam cell formation [62] and protecting against DNA damage [66] . It has been ]↑). Both CAT and MST can be found both in cytosol and mitochondrion. CBS is mostly located in cytosol. Hcy, homocysteine; PDE, phosphodiesterase; pO 2 , partial pressure of oxygen. [70] and previous studies from our group demonstrated [6] found that H 2 S attenuated inflammatory hepcidin partially by promoting SIRT1-mediated STAT3 deacetylation. SIRT3, one of the isoforms of SIRT family, has also been reported that it could be regulated by H 2 S to protect endothelial cells in an antioxidant manner [71] .
DNA damage and H 2 S
DNA damage accumulation is one of the notable features of atherosclerosis [72] . Mitochondrial DNA (mtDNA) damage has been reported as a risk factor independent of reactive oxygen species (ROS) to accelerate atherosclerosis by acing on VSMCs and monocytes [73] . In addition to mtDNA damage, VSMC DNA damage, including double-stranded breaks (DSBs) and DNA damage response activation, could alter plaque phenotype and inhibits fibrous cap areas, making it a novel target to exert salutary effects on plaque stability [74] . Interestingly, H 2 S ameliorates DNA damage in endothelial cells and fibroblasts via S-sulfhydration of MEK1 which leads to activation of PARP-1, thus attenuating cell senescence [75] . Besides, H 2 S maintains mtDNA replication and copy number by demethylation of mitochondrial transcription factor A (TFAM) [76] . Not limited to DNA itself, H 2 S can also remodel chromatin to modulate cytokine production [77] . Interestingly, CSE gene promoter was methylated by ox-LDL treatment in macrophages and in ApoE KO mice, which was recently reported by Du et al. [78] . It will be an interesting question whether H 2 S plays its anti-atherosclerotic role via repairing DNA both in nuclear and mitochondria. As to the role of VSMC in atherosclerosis, recently Feil [79] et al. reported that VSMC could transdifferentiate to macrophage-like cell during atherosclerosis, which had a significant effect of plaque stability because of loss of the balance of atherosclerotic composition. It will be just an question that whether any link exists between DNA damage, VSMC transdifferentiation and H 2 S. S-Propargyl-Cysteine (SPRC), an endogenous H 2 S initiator derived from garlic, could ameliorate DNA damage in doxorubicin-induced cardiotoxicity [80] . Schematic figure of H 2 S-exerted therapeutic effects could be transmitted to Fig. 3 . 
Evidence related to atherosclerosis prevention and treatment
Atherosclerosis, a chronic progression from very early stage [2] , inflammatory, cholesterol-rich lipids piling up disease, can principal morbidity and mortality worldwide [81] . Main therapeutic strategy to lower or reverse atherosclerosis is statins, but the clinical benefits of statins is somehow limited [82] . Surprisingly, recent reports have mentioned that treatment of statins can improve the H 2 S production, but it is the lipophilic atorvastatin, but not the hydrophilic pravastatin that increases the net H 2 S production [83] [84] [85] [86] [87] [88] . Recently, It is reported that estrogen evoked anti-atherosclerotic effects was mediated through CSEgenerated H 2 S [89] . Meanwhile, H 2 S has been proved to protect arteries from atherogenesis via various mechanisms.
Evidence has been piling up that H 2 S, a new star of gasotransmitter, plays a significant role in protecting susceptible arteries from atherogenesis via a variety of actions on certain types of cells. Detailed information could be referred to Table 1 . [106] reported that C57/Bl6 mice fed with a high fat diet up to 16 weeks showed a decrease of H 2 S producing enzymes which may contribute to later reducing endogenous H 2 S production and increased levels of plasma IL-6, IL 12p40 and G-CSF, though that of lipid deposition in aortae was inconspicuous and serum amyloid A (SAA) and C-reactive protein (CRP) did not change. CSE down regulation in atherosclerosis may partially attributed by microRNA-186 upregulation in THP-1 macrophages [107] . These evidence indicated that a high fat diet may trigger endogenous H 2 S production decline which is prior to apparent atherosclerotic disease.
Exogenous H 2 S treatment in apolipoprotein E (ApoE) knock out (KO) mice inhibits plaque progression. Hart et al. [108] reported that chronic treatment of sodium hydrosulfide in the final 4 weeks of 16-week high fat diet inhibited the development of vascular lesions and reduced systolic blood pressure whilst protected endothelium via causing reduction in vascular superoxide anion generation. However, inhibiting endogenous H 2 S generation with DL-propargylglycine (PAG) did not aggravate the lesion progression leading to the result that endogenous H 2 S is insufficient to abolish the atherogenesis. It is worth mentioning that PAG mediated CSE inhibition came at an incredibly high dosages (e.g., 50 mg/kg) and nonspecific effects [109] [110] [111] [112] .
Other researchers have reported the results in consist with aforementioned protective effects. Plasma H 2 S decreased and plasma and aortic intercellular adhesion molecule-1 (ICAM-1) increased in ApoE KO mice fed with a high fat diet, while size of atherosclerotic plaque shrank in NaHS treated ApoE KO mice and plaque size increased in ApoE KO mice administered with PAG [113] . Besides, NaHS inhibited ICAM-1 expression induced by tumor necrosis factor (TNF)-α stimulation via hampering IκB degradation in HUVECs [113] . Furthermore, Wang et al. [114] suggested that H 2 S inhibited progression of atherosclerosis in ApoE KO mice with high-fat diet via downregulating CX3CR1 and CX3CL1 expression on macrophages in the lesion plaque in vivo. In addition, exogenous NaHS achieved its beneficial effects on diabetes accelerated atherosclerosis by inducing KEAP1 sulfhydration and NRF2 activation [51] . Interestingly, NaHS exerted its anti-atherosclerosis effects through inducing protein S-nitrosylation [115] . Recent report unveiled that NaHS-induced anti-atherosclerotic effects could also be partially through up-regulating ATP-Binding Cassette Transporter A1 (ABCA1) [116] . In addition to the therapeutic effects of H 2 S, H 2 S could be a biomarker for ST-elevation myocardial infarction and unstable angina [117] .
Exogenous H 2 S exerts anti-atherosclerosis effect, but whether exogenous H 2 S can be physically translated to endogenous H 2 S in vivo is not clear. Knock out of CSE, CBS or 3-MST may be a feasible approach to estimate the effect of endogenous H 2 S on tissues and organs. CSE knock out (CSE KO) mice was first reported by Wang et al. and the gene deletion resulted in diminished endothelium-dependent vasorelaxation and profound hypertension [118] . Besides, deficit of CSE led to multiple pathological changes, including VSMCs overproliferation [119] , redox imbalances and apoptosis under hypoxia [101] , macrophage enhanced releasing of TNF-α induced by oxLDL (CSE knockdown) [120] . Furthermore, Mani et al. [121] reported that early fatty-streak lesions occurred in CSE KO mice fed with an atherogenic paigen-type diet for 12 weeks, together with increased oxidation stress, increased expression of adhesion molecules and exacerbated aortic intimal proliferation. However, wild-type mice fed with an atherogenic paigen-type diet or CSE KO mice fed with a normal chow diet did not develop any distinct atherosclerotic damage. Fed with a regular diet for 24weeks, ApoE KO mice and ApoE -/-/CSE -/-(DKO) mice developed atherosclerosis, whereas CSE KO mice and WT mice appeared normal [121] . Though ApoE KO mice and DKO mice shared several similar biomarkers including plasma cholesterol and LDL-cholesterol levels, DKO mice showed an accelerated atherosclerotic plaque rather than CSE KO mice. NaHS intervention reduced the atherosclerotic progress without affecting plasma lipid levels compared with ApoE KO mice, prompting that CSE may be a risk factor independent of plasma lipid homeostasis. Recently, ApoE KO mice overexpressing CSE (Tg/KO) showed an increased H 2 S generation in aortic tissue, reduced atherosclerotic plaque, alleviated plasma lipid profiles and down-regulated oxidative stress, supporting the assumption that CSE was a plausible approach to prevent atherogenesis [122] .
CBS KO mice showed mild and severe homocysteinemia because it is rate-limited enzyme consuming homocysteine to generate precursor of H 2 S. Besides, homozygous mutants suffered from severe growth retardation and the bulk of them died within 5 weeks after birth [123] . The plasma homocysteine level of homozygous and heterozygous mutants was 40 times and 2 times of that of WT mice, respectively. Considering high mortality of homozygous mice, heterozygous mice will be a feasible model for homocysteinemia [123] . In addition to homocysteinemia, CBS KO mice showed an abnormal lipid profiles, including markedly raised triglyceride and nonesterified fatty in serum and liver and serum elevated apolipoprotein B100 and very low density lipoprotein, which may be one of the causable factors of hepatic steatosis [124] . CBS deficit-induced homocysteinemia is involved in various pathogenesis. Hyperhomocysteinemia (HHcy) impairs EDHF induced relaxation in CBS deletion mice small mesenteric arteries by inhibiting SK/IK activities via imbalanced oxidative stress and tyrosine nitration-related mechanisms [125] . By introducing ApoE mutation into CBS KO mice (ApoE -/-/CBS -/-and ApoE -/-/CBS +/-mice), aortic lesions developed even without dietary manipulation, which indicated endogenous hyperhomocysteinemia was an independent factor for atherogenesis [126] . Interestingly, CBS homozygous mutant mice with zinc-inducible metallothionein promoter (Tg-hCBS) can circumvent the neonatal lethality of homozygous mutants [127] . By crossing ApoE KO mice with Tg-hCBS mice to create the Tg-hCBS ApoE -/-CBS -/-mice, fed with a high fat diet, severe HHcy exacerbated atherosclerosis and macrophages accumulation in lesions [128] . Additionally, homocysteine could in turn trigger inflammatory effects through inhibiting CSE expression via DNA hypermethylation on CSE promotor [129] .
Introducing endogenous deficiency of H 2 S, whether by knocking out of CSE or CBS, atherosclerosis accelerates, even early stage of atherosclerosis develops in ApoE -/-CSE -/-, ApoE -/-CBS -/-and Tg-hCBS ApoE -/-CBS -/-mice without diet manipulations. These in vivo evidence fully stress the importance of endogenous H 2 S in preventing atherogenesis.
Anti-atherosclerotic effect of H 2 S-releasing drugs
Considering short half-time period and dramatic blood concentration fluctuation of NaHS, it would be more ideal to apply H 2 S-releasing drugs to circumvent the defects of NaHS. GYY4137 exhibits anti-atherosclerotic effects in high-fat fed ApoE KO mice by downregulating vascular inflammation and oxidative stress, preserving endothelial function and reduced plaque formation achieved. Besides, GYY4137 could protect against myocardial fibrosis [130] . GYY4137 could also dilate arteries [131, 132] and attenuate fibrosis of myocytes [130] , which might also be implicated in atherosclerosis prevention [51] . S-aspirin (ACS14), another H 2 S-releasing chemical, also protects 12-week high-fat fed ApoE KO mice from atherosclerosis by 12-week treatment of ACS14 via reducing CX3CR1 expression in lesions and impeding atherogenesis and progress of atherosclerosis [133] . ACS14 also inhibits human platelet aggregation [105] and has strong antithrombotic effects [134] . In addition, Diallyl disulfide (DADS), organic sulfide donor which is derived from garlic, abolishes the deleterious effects of ox-LDL on NO production of eNOS [135] and suppresses ox-LDL-induced VCAM-1 and E-selectin expression [136] , which may somehow possesses the potential to improve atherosclerosis. Our recent investigation revealed that SPRC could prevent methionine and choline deficient diet-induced fatty liver through antioxidant pathways that were consistent with via which H 2 S exerted its antiatherosclerotic effects (Fig.  4) [51] , and H 2 S could be promising in preventing atherosclerosis [137] .
Conclusion and perspectives
We have summarized the known knowledge of H 2 S distribution, production and metabolism, physiological effect and molecular mechanisms related to vasculature, and profound significance of H 2 S in atherosclerotic progress and development. Finally, we point out some additional insights of mechanisms H 2 S may involve in, shedding new light of how H 2 S works to protect the precise architecture of the body. Although the full picture of this gas remains to be investigated into and the underlying mechanisms await to be further elucidated, the therapeutic effects of H 2 S and H 2 S-releasing chemicals are extremely promising. Drawbacks, rapid degradation and dramatic fluctuation, and whether the therapeutic effects in animal studies can be translated into clinical studies require to be considered discreetly. However, a steady H 2 S-releasing donor will be improved, not only for the research purpose but also for the safe and controlled therapeutic application based on H 2 S. In short, a better understanding of how H 2 S works to protect from atherosclerosis and the development of promising H 2 S-based therapy may pave the way for treating atherosclerosis in the future.
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